シノメニン

シノメニン 化学構造式
115-53-7
CAS番号.
115-53-7
化学名:
シノメニン
别名:
クコリン;(9α,13α,14α)-7,8-ジデヒドロ-4-ヒドロキシ-3,7-ジメトキシ-17-メチルモルフィナン-6-オン;コクリン;シノメニン;(1R,9S,10S)-3-ヒドロキシ-4,12-ジメトキシ-17-メチル-17-アザテトラシクロ[7.5.3.01,10.02,7]ヘプタデカ-2,4,6,11-テトラエン-13-オン
英語名:
Sinomenine
英語别名:
CUCOLINE;(4bR,8aS,9S)-4-hydroxy-3,7-dimethoxy-11-methyl-9,10-dihydro-5H-9,4b-(epiminoethano)phenanthren-6(8aH)-one;SNM;KUKOLINE;COCULINE;SINOMENIN;SabiaineA;SINOMENINE;SABIANINE A;y-17-methyl-
CBNumber:
CB4399085
化学式:
C19H23NO4
分子量:
329.39
MOL File:
115-53-7.mol

シノメニン 物理性質

融点 :
180 °C (dec.)(lit.)
比旋光度 :
D26 -71° (c = 2.1 in alc)
沸点 :
466.98°C (rough estimate)
比重(密度) :
1.2012 (rough estimate)
屈折率 :
1.5000 (estimate)
貯蔵温度 :
Store at +4°C
溶解性:
Soluble to 65 mg/mL (197.33 mM) in DMSO
酸解離定数(Pka):
9.72±0.40(Predicted)
Merck :
13,8620
InChIKey:
YMEVIMJAUHZFMW-VUIDNZEBSA-N
LogP:
1.245 (est)
安全性情報
  • リスクと安全性に関する声明
  • 危険有害性情報のコード(GHS)
主な危険性  T,Xn
Rフレーズ  45-46-23/24/25-36/37/38-20/21/22-48/20/22-40-22-63
Sフレーズ  53-22-26-36/37/39-45-36/37-24/25
RIDADR  1544
WGK Germany  3
RTECS 番号 QD2170000
9
国連危険物分類  6.1(b)
容器等級  III
HSコード  29399990
毒性 LD50 orally in mice: 580 mg/kg (Fu)
絵表示(GHS) GHS hazard pictogramsGHS hazard pictograms
注意喚起語 危険
危険有害性情報
コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード
H302 飲み込むと有害 急性毒性、経口 4 警告 GHS hazard pictograms P264, P270, P301+P312, P330, P501
H315 皮膚刺激 皮膚腐食性/刺激性 2 警告 GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 強い眼刺激 眼に対する重篤な損傷性/眼刺激 性 2A 警告 GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
H335 呼吸器への刺激のおそれ 特定標的臓器毒性、単回暴露; 気道刺激性 3 警告 GHS hazard pictograms
H351 発がんのおそれの疑い 発がん性 2 警告 P201, P202, P281, P308+P313, P405,P501
H372 長期にわたる、または反復暴露により臓器の障 害 特定標的臓器有害性、単回暴露 1 危険 GHS hazard pictograms P260, P264, P270, P314, P501
注意書き
P201 使用前に取扱説明書を入手すること。
P302+P352 皮膚に付着した場合:多量の水と石鹸で洗うこと。
P305+P351+P338 眼に入った場合:水で数分間注意深く洗うこと。次にコ ンタクトレンズを着用していて容易に外せる場合は外す こと。その後も洗浄を続けること。
P308+P313 暴露または暴露の懸念がある場合:医師の診断/手当てを 受けること。

シノメニン 価格 もっと(6)

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入
富士フイルム和光純薬株式会社(wako) W01W0119-1822 シノメニン
Sinomenine
115-53-7 20mg ¥13200 2024-03-01 購入
Sigma-Aldrich Japan Y0001208 European Pharmacopoeia (EP) Reference Standard
Sinomenine European Pharmacopoeia (EP) Reference Standard
115-53-7 y0001208 ¥20800 2024-03-01 購入
Sigma-Aldrich Japan 365602 0.3?mol chloroform of crystallization
Sinomenine 0.3?mol chloroform of crystallization
115-53-7 100mg ¥8470 2023-06-01 購入
キシダ化学株式会社(Kishida) 378-70893 シノメニン 99%
Sinomenine 99%
115-53-7 20mg ¥16000 2024-03-01 購入
キシダ化学株式会社(Kishida) 378-70892 シノメニン 99%
Sinomenine 99%
115-53-7 10mg ¥8000 2024-03-01 購入

シノメニン 化学特性,用途語,生産方法

解説

C19H23NO4(329.40).シノメニンは,ツヅラフジ科オオツヅラフジSinomenium acutumの根茎に含まれるモルヒネ型アルカロイド.無色の針状晶.融点161 ℃.[α]D"-71°(エタノール).エタノール,アセトン,クロロホルムに可溶,水,エーテル,ベンゼンに難溶.立体的にはモルヒネと対称の絶対配置をもっている.LD50 580 mg/kg(マウス,経口).森北出版「化学辞典(第2版)

説明

Isolated by Ohta from Cocculus diversifolius DC., this alkaloid forms colourless crystals from MeOH. It is stated to possess a powerful reflex action and to be aspasm stimulant, finally causing paralysis and death in toxic doses. It is also said to suppress the hypotensive action of dihydroxyphenylethanolethylamine.

物理的性質

Appearance: acicular crystals (crystallized from benzene). Solubility: soluble in ethanol, acetone, chloroform, and dilute alkali; slightly soluble in water, ether, and benzene. Melting point: 219–221?°C. Specific optical rotation:?– 71° (c?=?2.1, ethanol). Its hydrochloride, crystallization (water or ethanol), decomposed at 278?°C.?Its hydroiodide, needle crystal (crystallized from water), decomposed at 272?°C.?Its picrate, which is yellow needle crystal, decomposed at 176?°C.?Sinomenine is sensitive to light and heat to decompose.

来歴

The chemical structure of sinomenine is composed of four rings, A, B, C, and D, similar to the structure of morphine. Ring A is a benzene ring, and ring B is a half-chair-shaped, six-member ring. The C ring is a twisted-chair-type, sixmember ring that has an a, β-unsaturated ketone structure attached to the B ring. The D ring is a nitrogen-containing, sixmember ring under the B ring. Its structure is shown below; the current structural modification of sinomenine is mainly focused on the A/C active group.
Based on the transformation of the A ring, it was found that the 1-substituted formyl derivative of sinomenine showed the strongest inhibitory effect on the inflammatory response of the mouse ear. The 4-substituted p-chlorobenzoyl-sinomenine has the strongest anti-inflammatory and analgesic activity. The biotransformation and chemical synthesis were also used to prepare the di-sinomenine derivatives linked by carbon and carbon, which was stronger than that of sinomenine and had a strong inhibitory effect on cell inflammatory factors. Sinomenine derivatives of the C ring with a pyrazine ring have a strong inhibitory effect on T, B lymphocyte proliferation reaction, which can be used for the preparation of immunomodulatory drugs. The transformation of C ring carbonyl yielded a series of shift alkali derivatives, with strong anti-inflammatory and analgesic effects. These attempts are important for the development of new drugs.

使用

weak abortifacient, immunosuppressant, analgesic, antiinflammatory; LD50 (po) 580 mg/kg; (ip) 285 mg/kg(mouse)

適応症

It is mainly used for the treatment of rheumatoid arthritis and other types of rheumatism and arrhythmia in clinical.

生物活性

Natural anti-inflammatory morphinan analog. Causes degranulation of mast cells in mammalian tissues to release histamine and suppresses production of proinflammatory cytokines. Also displays antinociceptive activity, possibly through activation of the μ -opioid receptor. Stimulates short-term renewal of human embryonic stem cells (ESCs) in vitro .

臨床応用

The treatment of rheumatism and rheumatoid arthritis is one of the most important clinical applications of sinomenine. Sinomenine is particularly suitable for the treatment of arrhythmia caused by organic heart disease. Sinomenine is used for the treatment of glomerular disease, which can reduce urinary protein and relieve hematuria symptoms, and the side effects were significantly lower than that of tripterygium glycoside tablets, which are commonly used in clinical practice. In addition, sinomenine can significantly inhibit renal interstitial fibrosis and the production of tissue growth and growth factor TGF-β1. Sinomenine can significantly delay the development of chronic renal failure and effectively treat ankylosing spondylitis.

純化方法

Crystallise the salt from water (1g/1.5mL) or EtOH. The free base [115-53-7] M 329.4, has m 161o (from EtOH) (and again at 182o) after crystallisation from *C6H6, and [] D -78.9o (c 1, EtOH). The picrate has m 159-162o(dec) (from H2O). [Beilstein 21 II 470, 21 III/IV 6670.]

参考文献

Ohta., Ber. ges. Physiol., 33, 352 (1925)
Ohta, Kitasato., Arch. expo Med., 6, 259, 283 (1925)
Raymond-Hamet., Compt. rend. Soc. Biol., 125, 509 (1937)

シノメニン 上流と下流の製品情報

原材料

準備製品


シノメニン 生産企業

Global( 327)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Nanjing Finetech Chemical Co., Ltd.
025-85710122 17714198479
sales@fine-chemtech.com CHINA 885 55
Shanghai Zheyan Biotech Co., Ltd.
18017610038
zheyansh@163.com CHINA 3620 58
career henan chemical co
+86-0371-86658258
sales@coreychem.com China 29914 58
SHANDONG ZHI SHANG CHEMICAL CO.LTD
+86 18953170293
sales@sdzschem.com China 2931 58
Hubei Jusheng Technology Co.,Ltd.
18871490254
linda@hubeijusheng.com CHINA 28180 58
Xiamen AmoyChem Co., Ltd
+86-592-6051114 +8618959220845
sales@amoychem.com China 6387 58
NanJing Spring & Autumn Biological Engineering CO., LTD.
+8613815430202
sale02@cqherb.com CHINA 376 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873
sales@chemdad.com China 39916 58
Shanghai Standard Technology Co., Ltd.
18502101150
ft-sales@nature-standard.com CHINA 1923 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427
sales@conier.com China 49390 58

シノメニン  スペクトルデータ(1HNMR、IR、Raman)


115-53-7(シノメニン)キーワード:


  • 115-53-7
  • SINOMENINE
  • (9alpha,13alpha,14alpha)-7,8-didehydro-4-hydroxy-3,7-dimethoxy-17-methylmorphinan-6-one
  • (9Alpha,13alpha,14alpha)-4-hydroxy-3,7-dimethoxy-17-methyl-7,8-didehydromorphinan-6-one hydrochlo
  • Sinomenine (9alpha,13alpha,14alpha)-7,8-Didehydro-4-hydroxy-3,7-dimethoxy-17-methylmorphinan-6-one
  • Sinomenine 0.3 mol chloroform of crystallization
  • (9alpha,13alpha,14alpha)-4-hydroxy-3,7-dimethoxy-17-methyl-7,8-didehydromorphinan-6-one hydrochloride
  • Sinomenine, >=98%
  • Sinomenine/Sinomenine Hydrochloride
  • COCULINE
  • KUKOLINE
  • Sinomenine std.
  • Sinomenine SINOMENIN
  • SINOMENINE(RG)
  • Sinomenine hydrochorolide
  • Morphinan-6-one,7,8-didehydro-4-hydroxy-3,7-dimethoxy-17-methyl-,(9α,13α,14α)-
  • Sinomenine,Coculine,Cucoline,Tuduranine
  • (9a,13a,14a)-7,8-didehydro-4-hydroxy-3,7-dimethoxy-17-methylmorphinan-6-one
  • (9α,13α,14α)-7,8-Didehydro-4-hydroxy-3,7-dimethoxy-17-methylmorphinan-6-one
  • SINGLIROXBRUGHROSEFRUITP.E
  • 9α,13α,14α-7,8-Didehydro-4-hydroxy-3,7-dimethoxy-17-methylmorphinan-6-onehydrochloride
  • SNM
  • SinoMenine (Cucoline)
  • (+)-SinoMenine N-oxide
  • SinoMenine (6CI,7CI)
  • 7,8-didehydro-4-hydroxy-3,7-dimethoxy-17-methyl-9-alpha,13-alpha,14-alpha-mo
  • 9-alpha,13-alpha,14-alpha-morphinan-6-one,7,8-didehydro-4-hydroxy-3,7-dimethox
  • rphinan-6-one
  • y-17-methyl-
  • SABIANINE A
  • SINOMENIN
  • クコリン
  • (9α,13α,14α)-7,8-ジデヒドロ-4-ヒドロキシ-3,7-ジメトキシ-17-メチルモルフィナン-6-オン
  • コクリン
  • シノメニン
  • (1R,9S,10S)-3-ヒドロキシ-4,12-ジメトキシ-17-メチル-17-アザテトラシクロ[7.5.3.01,10.02,7]ヘプタデカ-2,4,6,11-テトラエン-13-オン
Copyright 2017 © ChemicalBook. All rights reserved